The company was listed on the JSE in the 1990s via Medhold Limited before management effected a buyout in 1998. Since then, Medhold has expanded its operations through a combination of organic growth, acquisitions, and new product introductions across Southern Africa.
With Sanlam Private Equity as the majority shareholder, Medhold has a strong and stable financial foundation to support continued growth and the delivery of high-quality healthcare solutions throughout the region. The company holds a Level 2 BBBEE rating, reflecting its ongoing commitment to transformation and regulatory compliance in South Africa.
